Reclassifies testosterone as controlled substance

The California Legislature approved file 202520260AB1778 ("Reclassifies testosterone as controlled substance"), by a recorded vote of 116 to 0. Last action: August 24, 2026.

California file 202520260AB1778, before the California Legislature. Passed as of 2026-08-24.

What it does

Prescriptions require new licensing and reporting rules Patients prescribed testosterone for medical conditions will need doctors to comply with controlled-substance dispensing requirements, potentially adding delays or documentation steps to refills.

The bigger picture

Telemedicine and retail clinics face new compliance burden Online testosterone providers and non-physician clinics will face higher licensing and recordkeeping requirements, which may reduce low-cost access points and concentrate prescribing in traditional medical offices.

What to watch

Legitimate medical users may face supply or access friction Patients with diagnosed hypogonadism or other medically appropriate uses risk prescription delays, pharmacy shortages, or reduced willingness of providers to prescribe if regulatory burden becomes onerous.

How they voted

Yes (116)

Read the official record for 202520260AB1778

See everything up for a vote · This week in California · See what we have filed with the clerk